1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34710737 | FLT3 inhibition by olverembatinib (HQP1351) downregulates MCL-1 and synergizes with BCL-2 inhibitor lisaftoclax (APG-2575) in preclinical models of FLT3-ITD mutant acute myeloid leukemia. | 2022 Jan | 1 |